Cytembena treatment of advanced gynaecological carcinomas.
D000179:Acrylates / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001201:Ascites / Q000188:drug therapy; D001565:Benzoates / Q000494:pharmacology; D001966:Bromine / Q000494:pharmacology; D003520:Cyclophosphamide / Q000627:therapeutic use; D003581:Cytodiagnosis; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D007065:Idoxuridine; D007457:Iodine Radioisotopes; D010051:Ovarian Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy; D014846:Vulvar Neoplasms / Q000188:drug therapy
D000179:Acrylates; D000970:Antineoplastic Agents; D001565:Benzoates; D007457:Iodine Radioisotopes; D003520:Cyclophosphamide; D007065:Idoxuridine; D001966:Bromine